Abstract
Cancer is a complex disease that develops due to complex interactions between hereditary and environmental variables. This devastating disease has far-reaching consequences for human health, communities, and the economy. Therefore, there is a pressing need to improve techniques for detecting, diagnosing, and treating cancer. In recent times, the discipline of materials science has witnessed a significant advancement in metal–organic frameworks, more frequently referred to as MOFs. Metal-organic frameworks (MOFs) have recently garnered considerable attention owing to their immense potential and adaptability in various applications. Notably, they have shown great promise as effective carriers for delivering therapeutic compounds and as precise tools for targeting cancer cells. The intentional manipulation of metal–organic frameworks (MOFs) has endowed them with the distinct ability to selectively release pharmaceutical agents in response to particular stimuli. This attribute has significant potential for the development of externally controlled cancer treatments. This review highlights the current developments in MOF synthesis, highlighting the unique properties that make MOFs ideal for therapeutic applications. We will delve deeply into the benefits of these innovations, focusing on how they can be used in cancer therapy. We will also closely examine their challenges and the potential future applications of intelligent nanobiomaterials in cancer medicine delivery systems.
| Original language | English |
|---|---|
| Article number | 111056 |
| Journal | Microchemical Journal |
| Volume | 204 |
| DOIs | |
| State | Published - Sep 2024 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Cancer
- Controlled release
- Drug delivery systems
- Metal-Organic Frameworks
- Porous nanomaterials
- Targeted therapy
Fingerprint
Dive into the research topics of 'Comprehensive overview of utilizing metal-organic frameworks (MOFs) for precise cancer drug delivery'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver